Hypermarcas SA : Pharmaceuticals and Healthcare-Company Profile, SWOT and Financial Analysis

Hypermarcas SA : Pharmaceuticals and Healthcare-Company Profile, SWOT and Financial Analysis


  Request for Sample Report
  Request A Quote

Executive Summary

ICD Research's "Hypermarcas SA : Pharmaceuticals and Healthcare-Company Profile, SWOT & Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.

Key Findings

This report is a crucial resource for industry executives and anyone looking to access key information about "Hypermarcas SA"

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis

Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Quimica Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.

This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

The SWOT analysis identifies the company's strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

Reasons To Buy

Quickly enhance your understanding of "Hypermarcas SA"

Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

Increase business/sales activities by understanding your competitors' businesses better.

Recognize potential partnerships and suppliers.

Key Highlights

Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Quimica Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Hypermarcas SA-Key Employees

2 Hypermarcas SA-Major Products and Services

3 Hypermarcas SA-History

4 Hypermarcas SA-Company Statement

5 Hypermarcas SA-Locations and Subsidiaries

5.1 Hypermarcas SA-Head Office

5.2 Hypermarcas SA-Other Locations and Subsidiaries

6 Hypermarcas SA-Business Analysis

6.1 Hypermarcas SA-Company Overview

6.2 Hypermarcas SA-Business Description

7 Hypermarcas SA-SWOT Analysis

7.1 Hypermarcas SA-SWOT Analysis-Overview

7.2 Hypermarcas SA-Strengths

7.2.1 Strength-Strengthening Liquidity Position

7.2.2 Strength-Strong Financial Performance

7.2.3 Strength-Diverse Brands and Product Portfolio

7.3 Hypermarcas SA-Weaknesses

7.3.1 Weakness-Overdependence on Brazilian market

7.4 Hypermarcas SA-Opportunities

7.4.1 Opportunity-New Product Launch

7.4.2 Opportunity-Growing Pharmaceutical Market

7.4.3 Opportunity-Business Reorganization

7.5 Hypermarcas SA-Threats

7.5.1 Threat-Declining Economy of Brazil

7.5.2 Threat-Competitive Landscape

7.5.3 Threat-Industry Regulations

8 Hypermarcas SA-Company Financial Analysis

8.1 Hypermarcas SA-Five Year Snapshot: Overview of Financial and Operational Performance Indicators

9 Hypermarcas SA-Interim ratios

9.1.1 Hypermarcas SA-Financial ratios: Capital Market Ratios

9.2 Hypermarcas SA-Financial Performance and Ratio Charts

9.2.1 Hypermarcas SA-Revenue and Operating margin

9.2.2 Hypermarcas SA-Asset and Liabilities

9.2.3 Hypermarcas SA-Net Debt vs. Gearing Ratio

9.2.4 Hypermarcas SA-Operational Efficiency

9.2.5 Hypermarcas SA-Solvency

9.2.6 Hypermarcas SA-Valuation

9.3 Hypermarcas SA-Competitive Benchmarking

9.3.1 Hypermarcas SA-Market Capitalization

9.3.2 Hypermarcas SA-Efficiency

9.3.3 Hypermarcas SA-Valuation

9.3.4 Hypermarcas SA-Turnover: Inventory and Asset

9.3.5 Hypermarcas SA-Liquidity

10 Hypermarcas SA-Mergers & Acquisitions and Partnerships

10.1 Hypermarcas SA-M&A and Partnerships Strategy

11 Hypermarcas SA-Recent Developments

12 Appendix

12.1 Methodology

12.2 Hypermarcas SA-Ratio Definitions

12.3 Disclaimer

Figure 1: Hypermarcas SA-Revenue and Operating Profit

Figure 2: Hypermarcas SA-Asset and Liabilities

Figure 3: Hypermarcas SA-Net Debt vs. Gearing Ratio

Figure 4: Hypermarcas SA-Operational Efficiency

Figure 5: Hypermarcas SA-Solvency

Figure 6: Hypermarcas SA-Valuation

Figure 7: Hypermarcas SA-Market Capitalization

Figure 8: Hypermarcas SA-Efficiency

Figure 9: Hypermarcas SA-Valuation

Figure 10: Hypermarcas SA-Turnover: Inventory and Asset

Figure 11: Hypermarcas SA-Liquidity

Table 1: Hypermarcas SA-Key Employees

Table 2: Hypermarcas SA-Major Products and Services

Table 3: Hypermarcas SA-History

Table 4: Hypermarcas SA-Subsidiaries

Table 5: Hypermarcas SA-Annual ratios

Table 6: Hypermarcas SA-Interim ratios

Table 7: Hypermarcas SA-Capital Market Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Hypermarcas SA

Hypermarcas SA, Brazil, Pharmaceuticals and Healthcare, ICD Research, company overview, key facts, business description, SWOT analysis, strengths, weaknesses, opportunities, threats, mergers & acquisitions, key employees, competitive benchmarking, employee biographies & locations and subsidaries.

select a license
Single User License
USD 125 INR 9168
Site License
USD 250 INR 18335
Corporate User License
USD 375 INR 27503

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com